signal
lymphocyt
activ
molecul
slam
express
inhibit
cell
line
use
sirna
effect
slam
inhibit
pest
de
petit
rumin
viru
pprv
replic
infect
titr
studi
slam
suppress
assess
use
realtim
pcr
flow
cytometri
confirm
suppress
mrna
protein
level
respect
three
chemic
synthes
sirna
transfect
individu
use
oligofectamin
cell
line
result
slam
suppress
comparison
untransfect
cell
line
slam
suppress
cell
line
infect
pprv
replic
reduc
viru
titr
reduc
log
sirna
show
potent
inhibit
slam
express
mrna
protein
level
also
caus
maximum
reduct
viru
replic
viru
titr
reduct
pprv
titr
seen
antislam
antibodi
neutral
cell
line
confirm
slam
one
co
receptor
pprv
howev
presenc
put
viru
receptor
isar
rule
way
cell
respond
dsrna
silenc
homolog
gene
reveal
new
approach
studi
function
mani
unexplor
exist
gene
rna
interfer
rnai
technolog
employ
unleash
dormant
potenti
sequenc
genom
identifi
target
drug
design
silenc
diseasecaus
mutant
allel
specif
ex
vivo
manipul
stem
cell
delay
age
process
etc
also
exploit
power
tool
prevent
viru
multipl
alreadi
proven
inhibit
replic
spread
mani
virus
hu
et
al
mohapatra
et
al
mallanna
et
al
pest
de
petit
rumin
ppr
viral
diseas
goat
sheep
widespread
distribut
across
subsaharan
africa
arabian
peninsula
indian
subcontin
nanda
et
al
caus
agent
pest
de
petit
rumin
viru
pprv
classifi
morbilliviru
genu
famili
paramyxovirida
genu
also
includ
rinderpest
viru
rpv
canin
distemp
viru
cdv
human
measl
viru
mv
virus
marin
mammal
phocin
distemp
viru
seal
cetacean
morbilliviru
isol
dolphin
porpois
tatsuo
et
al
dhar
et
al
cellular
receptor
one
major
determin
host
rang
tissu
tropism
virus
signal
lymphocyt
activ
molecul
slam
molecul
report
receptor
mv
tatsuo
et
al
cdv
tatsuo
et
al
seki
et
al
rpv
tatsuo
et
al
rnai
could
silenc
slam
express
inhibit
mv
infect
cell
hu
et
al
slam
kda
glycoprotein
belong
subset
immunoglobulin
ig
superfamili
express
surfac
proport
primari
b
cell
epsteinbarr
viru
ebv
transform
b
cell
activ
cell
memori
cell
cell
clone
immatur
thymocyt
tangy
et
al
present
studi
aim
determin
effect
slam
suppress
cell
line
pprv
replic
adher
cell
line
procur
indian
veterinari
research
institut
mukteshwar
india
maintain
laboratori
use
small
interf
si
rna
transfect
growth
assay
pprv
total
rna
extract
cell
line
either
infect
pprv
alon
transfect
sirna
use
trizol
invitrogen
usa
cdna
synthes
use
high
capac
cdna
archiv
kit
appli
biosystem
inc
usa
use
endogen
control
realtim
pcr
separ
mastermix
prepar
endogen
control
target
gene
slam
pprv
gene
use
taqman
univers
pcr
master
mix
appli
biosystem
inc
usa
l
taqman
primer
probe
l
ng
cdna
adjust
l
depc
water
give
total
reaction
volum
l
reaction
prepar
triplic
notempl
control
ntc
prepar
use
depc
water
instead
cdna
plate
centrifug
cool
c
plate
centrifug
rpm
min
rid
mix
air
bubbl
plate
kept
insid
realtim
pcr
machin
appli
biosystem
inc
usa
model
well
locat
accord
ntc
target
endogen
control
use
softwar
machin
program
run
use
follow
univers
cycl
condit
consist
one
cycl
c
min
one
cycl
c
min
cycl
c
c
min
ct
valu
record
target
endogen
control
data
accept
ntc
amplif
primer
probe
use
endogen
control
target
gene
shown
tabl
sirna
design
use
onlin
softwar
tool
avail
ambion
websit
wwwambioncom
differ
sirna
select
differ
region
target
gene
transfect
optim
done
differ
concentr
transfect
reagent
oligofectamin
invitrogen
usa
differ
concentr
sirna
differ
cell
densiti
sirna
transfect
cell
use
method
describ
volinia
et
al
ovchrenko
et
al
briefli
l
oligofectamin
invitrogen
usa
ad
l
optimem
invitrogen
usa
mix
gentli
incub
min
room
temperatur
pmol
sirna
l
stock
ad
l
optimem
mix
gentli
kept
min
incub
sirna
oligofectamin
complex
mix
kept
incub
c
min
meanwhil
cell
trypsin
cell
count
use
haemocytomet
cell
concentr
use
sirna
transfect
sirna
oligofectamin
complex
total
volum
l
per
well
ad
well
plate
l
optimem
ad
well
cell
ad
well
antibiot
free
growth
medium
fc
ad
make
final
volum
l
cell
incub
co
c
h
h
incub
media
chang
pmol
sirna
ad
cell
pmol
sirna
l
oligofectamin
cell
incub
co
c
next
h
h
post
origin
sirna
transfect
one
set
cell
use
rna
extract
studi
inhibit
slam
use
realtim
pcr
anoth
set
cell
infect
tcid
pprv
h
initi
sirna
transfect
cytopath
effect
cpe
observ
h
post
viru
infect
cell
frozenthaw
use
viru
titrat
dhinakar
raj
et
al
anoth
set
cell
use
rna
extract
studi
effect
slam
inhibit
viru
replic
term
pprv
gene
express
neg
control
chemic
synthes
sirna
design
newcastl
diseas
viru
ndv
part
anoth
studi
use
flow
cytometri
use
assess
reduct
slam
express
follow
sirna
transfect
cell
use
anti
human
slamfitc
conjug
ebiosci
usa
crossreact
slam
briefli
h
post
sirna
transfect
cell
trypsin
cell
count
suspend
concentr
per
ml
medium
cell
pellet
rpm
min
antihuman
slam
fitc
ad
cell
pellet
lmillion
cell
incub
c
min
cell
wash
fac
buffer
pb
hors
serum
sodium
azid
resuspend
l
fac
buffer
becton
dickinson
usa
flow
cytometri
analysi
fac
calibur
machin
becton
dickinson
usa
use
cell
quest
softwar
ten
thousand
cell
count
slam
express
normal
cell
cell
count
sirna
transfect
cell
neg
control
sirna
specif
newcastl
diseas
viru
use
slam
express
assess
three
differ
sampl
time
triplic
mean
percentag
cell
express
slam
record
flow
cytometri
ct
valu
record
gene
express
assay
realtim
pcr
ct
valu
mean
triplic
sampl
test
least
three
independ
sampl
test
occas
ct
valu
indic
differ
ct
valu
target
gene
endogen
gene
ct
valu
indic
differ
ct
sampl
ct
calibr
calibr
chosen
slam
express
untransfect
cell
line
fold
chang
gene
express
calcul
ct
correl
coeffici
calcul
fold
chang
use
ms
excel
packag
confirm
slam
act
receptor
pprv
infect
inhibit
assay
perform
follow
alpha
neutral
method
constant
antibodi
variabl
viru
use
convent
virolog
briefli
cell
grown
plate
overnight
co
cell
incub
c
h
medium
contain
antihuman
slam
antibodi
ebiosci
usa
g
per
well
constant
antibodi
one
hour
treatment
antislam
antibodi
cell
infect
three
well
dilut
cell
adapt
pprv
variabl
viru
appropri
control
treat
irrelev
antibodi
poultri
viru
infecti
bronchiti
viru
avail
depart
anim
biotechnolog
madra
veterinari
colleg
chennai
also
includ
h
incub
cpe
observ
antibodi
neutral
unneutr
cell
presenc
pprv
well
also
confirm
use
haemagglutin
assay
chicken
red
blood
cell
dhinakar
raj
et
al
calcul
viru
titr
neutral
index
calcul
differ
pprv
titr
slam
antibodi
neutral
cell
unneutr
cell
one
requir
use
rel
quantif
method
pcr
effici
target
endogen
control
similar
slope
standard
curv
determin
pcr
effici
slam
beta
actin
slope
standard
curv
gener
use
differ
dilut
concentr
cdna
respect
calcul
pcr
effici
slam
beta
actin
respect
indic
comparison
use
rel
quantif
accept
pcr
effici
pprv
gene
also
slam
express
sirna
transfect
cell
line
shown
tabl
sirna
result
decreas
slam
express
result
increas
ct
valu
realtim
pcr
untreat
cell
increas
ct
valu
rang
cycl
endogen
control
beta
actin
ct
valu
rang
cycl
decreas
slam
express
rang
maximum
decreas
seen
sirna
transfect
cell
neg
control
sirna
transfect
show
neglig
decreas
slam
express
confirm
reduct
slam
express
protein
level
flow
cytometri
perform
sirna
transfect
cell
use
antihuman
slamfitc
conjug
result
flow
cytometri
analysi
depict
tabl
fig
percent
normal
cell
express
slam
take
percent
express
sirna
transfect
decreas
slam
express
rang
neg
control
sirna
inhibit
level
correl
realtim
pcr
result
sirna
show
highest
decreas
slam
express
protein
level
also
sirna
transfect
cell
show
less
pronounc
cpe
follow
pprv
infect
h
postinfect
pi
normal
sirna
transfect
pprv
infect
cell
exhibit
balloon
syncytium
format
sirna
transfect
cell
show
clump
round
time
point
tabl
show
effect
slam
inhibit
pprv
replic
viru
titr
cell
line
decreas
slam
express
result
increas
ct
valu
realtim
pcr
pprv
gene
express
increas
ct
valu
rang
cycl
endogen
control
beta
actin
ct
valu
rang
cycl
fold
decreas
viru
replic
express
pprv
gene
assess
taqman
chemistri
vari
differ
sirna
test
also
reflect
decreas
infect
viru
titr
rang
log
time
transfect
cell
show
maximum
decreas
viru
replic
viru
titr
log
time
viru
titr
antislam
antibodi
neutral
cell
calcul
tcid
slam
neutral
cell
reduc
tcid
base
haemagglutin
test
indic
presenc
viru
neutral
index
cpe
also
delay
slam
block
cell
slam
unneutr
cell
exhibit
cell
round
h
postinfect
fig
syncytium
format
h
pi
fig
howev
slam
block
cell
chang
seen
h
pi
fig
cell
round
evid
h
pi
fig
cellular
receptor
one
major
determin
host
rang
tissu
tropism
virus
differ
virus
use
differ
receptor
acetylcholin
rabi
viru
lentz
et
al
tabl
express
slam
cell
line
inhibit
sirna
transfect
assess
use
flow
cytometri
antihuman
slamfitc
conjug
human
aminopeptidas
n
hapn
human
corona
viru
breslin
et
al
sialic
acid
influenza
viru
suzuki
et
al
slam
shown
receptor
mv
tatsuo
et
al
cdv
seki
et
al
rpv
baron
belong
morbilliviru
genu
howev
respect
anoth
viru
pprv
also
belong
genu
indirect
evid
slam
could
one
receptor
sreenivasa
et
al
shown
pprv
viru
grew
higher
titr
cell
express
slam
compar
vero
cell
express
slam
howev
fact
pprv
caus
haemmaglutin
pig
chicken
rbc
monoharan
et
al
may
suggest
sialic
acid
residu
could
act
ppr
viral
receptor
background
propos
studi
undertaken
find
whether
slam
act
receptor
pprv
rnai
technolog
clearli
signific
potenti
analyz
critic
gene
function
identifi
test
new
target
diseas
larg
number
gene
function
resolv
recent
past
use
sirna
technolog
mani
attempt
laboratori
world
zou
et
al
moskalenko
et
al
bakker
et
al
henc
studi
approach
tri
elucid
specif
role
slam
pprv
replic
vitro
cell
line
use
sinc
cell
line
constitut
express
slam
sinc
studi
involv
identif
receptor
viru
essenti
viru
infect
done
time
potenti
viru
receptor
express
highli
suppress
would
ensur
viru
would
inhibit
entri
suscept
cell
studi
involv
suppress
viral
gene
possibl
sirna
viru
given
togeth
case
hour
interv
sirna
directli
inhibit
viru
replic
entri
hu
et
al
mohapatra
et
al
li
ding
sirna
transfect
cell
lower
level
slam
express
use
pprv
infect
slam
receptor
requir
pprv
viru
entri
viru
replic
lower
level
slam
suppress
cell
effect
seen
delay
cpe
decreas
viru
titr
viru
replic
assess
realtim
pcr
howev
viru
replic
complet
inhibit
sirna
thu
seem
like
slam
use
receptor
pprv
slam
level
suppress
viru
entri
reduc
viru
cpe
delay
viru
replic
titr
lower
level
folddecreas
slam
express
highli
correl
decreas
viru
titr
differ
sirna
treat
cell
correl
coeffici
similarli
although
decreas
pprv
gene
slam
express
also
highli
correl
correl
coeffici
magnitud
decreas
case
slam
rather
pprv
gene
express
viru
titr
could
probabl
slam
constitut
express
cell
pprv
gene
express
could
vari
base
viru
replic
statu
decreas
infect
viru
titr
slam
suppress
cell
rang
log
may
due
fact
slam
level
although
reduc
total
abolish
residu
presenc
slam
could
use
pprv
entri
anoth
possibl
could
possibl
usag
receptor
pprv
case
mv
addit
slam
also
shown
play
import
role
viru
entri
dorig
et
al
nanich
et
al
slam
block
use
antibodi
viru
titr
decreas
give
unequivoc
proof
slam
one
co
receptor
pprv
sinc
could
also
possibl
inhibit
slam
express
sirna
inhibit
cellular
function
may
affect
viru
replic
viru
product
howev
presenc
receptor
rule
sinc
viru
titr
complet
block
pprv
also
isol
cultiv
cell
line
vero
express
slam
rk
singh
grate
acknowledg
work
partli
fund
depart
biotechnolog
new
delhi
